Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Polycystic Ovary Syndrome × Sitagliptin Phosphate × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 5 empagliflozin 2 Tablets 2 Letrozole 2 Clomiphene 2 thymoquinone 1 semaglutide 1 penclomedine 1 Vaginal Creams, Foams, and Jellies 1 Sitagliptin Phosphate 1 Ovidrel 1 Inositol 1 Folic Acid 1 Exenatide 1 Curcumin 1 Crinone 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05972928 2023-08-02

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Beni-Suef University

Phase 2/3 Unknown

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡